<p>C57BL/6 mice were immunized with an empty vector, cytokines only, or D/P vaccine (V1 dose: TcG2- and TcG4-encoding plasmids ± IL-12- and GMCSF-expression plasmids; and V2 dose: recombinant TcG2 and TcG4 proteins), as detailed in Materials and Methods. <b>(A&B)</b> Splenocytes were obtained at 14 days post-vaccination (dpv) and <i>ex vivo</i> labeled with PE-conjugated anti-CD4, FITC-conjugated anti-CD8, PerCPCy5.5-conjugated anti-CD62L, and APC-conjugated anti-CD44 antibodies. Shown are the PE<sup>+</sup>CD4<sup>+</sup><b><i>(A)</i></b> and FITC<sup>+</sup>CD8<sup>+</sup><b><i>(B)</i></b> T cell subsets that were of effector/effector memory (T<sub>EM:</sub> CD44<sup>+</sup>CD62L<sup>-</sup>) and central memory (T<sub>CM,</sub> CD44<sup>+...
<p>SIV-specific T cells with 1–4 cytokine (IFN-γ, TNF-α, IL-2) or cytolytic (CD107a) effector functi...
<p>Mice were vaccinated using <i>in vivo</i> EP with 20 µg of the indicated p24CE1 (left panel) or p...
K vaccinated (PBS). Two weeks after the adenoviral vector booster immunization, mice were challenged...
<p>Mice were vaccinated as in <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal...
<p>Mice were immunized with D/P vaccine followed by a booster dose as in <a href="http://www.plospat...
<p><b>A</b> & <b>B</b>) Balb/c mice were immunized i.m. at weeks 0 and 2 with 50 µg of pSG2-Ag85A or...
<p>Mice were primed two times by immunization with the pCGWHc plasmid. Four weeks later boosting imm...
<p><b>(A)</b> Mice (N = 5/group) were vaccinated 3 times (week 0, 3 and 6) with 20 µg of a plasmid e...
<p>BALB/c mice (n = 20 mice/group) were immunized with DNA or adenovectors as indicated. (A) Schemat...
<p>C57BL/6 mice were vaccinated with 25 μg of the indicated plasmids on days 0 and 21. One day follo...
<p>Mice were immunized twice via the IM route with DNA vaccine encoding Ag85B and/or flagellin as sh...
<p><b>(A)</b> Immunization schedule of animals. Balb/c mice were inoculated with 100 μg of respectiv...
<p>Groups of BALB/c mice (4 per group) were immunized in prime/boost as indicated in <a href="http:/...
(A) Splenocytes from mice immunized with the DNA vaccine candidates were collected 1 week after the ...
<p>BALB/c mice were immunized by one single DNA injection in each quadriceps muscle in the absence o...
<p>SIV-specific T cells with 1–4 cytokine (IFN-γ, TNF-α, IL-2) or cytolytic (CD107a) effector functi...
<p>Mice were vaccinated using <i>in vivo</i> EP with 20 µg of the indicated p24CE1 (left panel) or p...
K vaccinated (PBS). Two weeks after the adenoviral vector booster immunization, mice were challenged...
<p>Mice were vaccinated as in <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal...
<p>Mice were immunized with D/P vaccine followed by a booster dose as in <a href="http://www.plospat...
<p><b>A</b> & <b>B</b>) Balb/c mice were immunized i.m. at weeks 0 and 2 with 50 µg of pSG2-Ag85A or...
<p>Mice were primed two times by immunization with the pCGWHc plasmid. Four weeks later boosting imm...
<p><b>(A)</b> Mice (N = 5/group) were vaccinated 3 times (week 0, 3 and 6) with 20 µg of a plasmid e...
<p>BALB/c mice (n = 20 mice/group) were immunized with DNA or adenovectors as indicated. (A) Schemat...
<p>C57BL/6 mice were vaccinated with 25 μg of the indicated plasmids on days 0 and 21. One day follo...
<p>Mice were immunized twice via the IM route with DNA vaccine encoding Ag85B and/or flagellin as sh...
<p><b>(A)</b> Immunization schedule of animals. Balb/c mice were inoculated with 100 μg of respectiv...
<p>Groups of BALB/c mice (4 per group) were immunized in prime/boost as indicated in <a href="http:/...
(A) Splenocytes from mice immunized with the DNA vaccine candidates were collected 1 week after the ...
<p>BALB/c mice were immunized by one single DNA injection in each quadriceps muscle in the absence o...
<p>SIV-specific T cells with 1–4 cytokine (IFN-γ, TNF-α, IL-2) or cytolytic (CD107a) effector functi...
<p>Mice were vaccinated using <i>in vivo</i> EP with 20 µg of the indicated p24CE1 (left panel) or p...
K vaccinated (PBS). Two weeks after the adenoviral vector booster immunization, mice were challenged...